BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 37256432)

  • 1. Comparative structural study of selective and non-selective NSAIDs against the enzyme cyclooxygenase-2 through real-time molecular dynamics linked to post-dynamics MM-GBSA and e-pharmacophores mapping.
    Ganai SA; Rajamanikandan S; Shah BA; Lone A; Arwa F; Malik FA
    J Mol Model; 2023 May; 29(6):192. PubMed ID: 37256432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aryl/heteroaryl Substituted Celecoxib Derivatives as COX-2 Inhibitors: Synthesis, Anti-inflammatory Activity and Molecular Docking Studies.
    Madhava G; Ramana KV; Sudhana SM; Rao DS; Kumar KH; Lokanatha V; Rani AU; Raju CN
    Med Chem; 2017; 13(5):484-497. PubMed ID: 28228088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Whole-Body PET Imaging in Humans Shows That
    Kim MJ; Anaya FJ; Manly LS; Lee JH; Hong J; Shrestha S; Telu S; Henry K; Santamaria JAM; Liow JS; Zanotti-Fregonara P; Shetty HU; Zoghbi SS; Pike VW; Innis RB
    J Nucl Med; 2023 Jan; 64(1):159-164. PubMed ID: 35798558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-inflammatory effects of aspirin and sodium salicylate.
    Amann R; Peskar BA
    Eur J Pharmacol; 2002 Jun; 447(1):1-9. PubMed ID: 12106797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel Molecular Mechanism of Aspirin and Celecoxib Targeting Mammalian Neuraminidase-1 Impedes Epidermal Growth Factor Receptor Signaling Axis and Induces Apoptosis in Pancreatic Cancer Cells.
    Qorri B; Harless W; Szewczuk MR
    Drug Des Devel Ther; 2020; 14():4149-4167. PubMed ID: 33116404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of novel cyclooxygenase-2 selective inhibitors using pharmacophore models.
    Palomer A; Cabré F; Pascual J; Campos J; Trujillo MA; Entrena A; Gallo MA; García L; Mauleón D; Espinosa A
    J Med Chem; 2002 Mar; 45(7):1402-11. PubMed ID: 11906281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An Insilico evaluation of phytocompounds from Albizia amara and Phyla nodiflora as cyclooxygenase-2 enzyme inhibitors.
    Loganathan Y; Jain M; Thiyagarajan S; Shanmuganathan S; Mariappan SK; Kizhakedathil MPJ; Saravanakumar T
    Daru; 2021 Dec; 29(2):311-320. PubMed ID: 34415547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppression of inducible cyclooxygenase 2 gene transcription by aspirin and sodium salicylate.
    Xu XM; Sansores-Garcia L; Chen XM; Matijevic-Aleksic N; Du M; Wu KK
    Proc Natl Acad Sci U S A; 1999 Apr; 96(9):5292-7. PubMed ID: 10220459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular insights in repurposing selective COX-2 inhibitor celecoxib against matrix metalloproteinases in potentiating delayed wound healing: a molecular docking and MMPB/SA based analysis of molecular dynamic simulations.
    Mude L; Jupudi S; Swaroop AK; Tallapaneni V; Karri VVSR
    J Biomol Struct Dyn; 2024 Mar; 42(5):2437-2448. PubMed ID: 37160705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of plasma protein on the potencies of inhibitors of cyclooxygenase-1 and -2.
    Warner TD; Vojnovic I; Bishop-Bailey D; Mitchell JA
    FASEB J; 2006 Mar; 20(3):542-4. PubMed ID: 16403783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aspirin, but not NO-releasing aspirin (NCX-4016), interacts with selective COX-2 inhibitors to aggravate gastric damage and inflammation.
    Wallace JL; Zamuner SR; McKnight W; Dicay M; Mencarelli A; del Soldato P; Fiorucci S
    Am J Physiol Gastrointest Liver Physiol; 2004 Jan; 286(1):G76-81. PubMed ID: 14665439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, synthesis and biological assessment of new selective COX-2 inhibitors including methyl sulfonyl moiety.
    Sağlık BN; Osmaniye D; Levent S; Çevik UA; Çavuşoğlu BK; Özkay Y; Kaplancıklı ZA
    Eur J Med Chem; 2021 Jan; 209():112918. PubMed ID: 33071054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cyclooxygenase (COX)-2 selective inhibitors: aspirin, a dual COX-1/COX-2 inhibitor, to COX-2 selective inhibitors].
    Nakamura H
    Nihon Yakurigaku Zasshi; 2001 Sep; 118(3):219-30. PubMed ID: 11577463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Role of Celecoxib as a Potential Inhibitor in the Treatment of Inflammatory Diseases - A Review.
    Cruz JV; Rosa JMC; Kimani NM; Giuliatti S; Dos Santos CBR
    Curr Med Chem; 2022; 29(17):3028-3049. PubMed ID: 34514981
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dual Effects of Cyclooxygenase Inhibitors in Combination With CD19.CAR-T Cell Immunotherapy.
    Yang M; Wang L; Ni M; Neuber B; Wang S; Gong W; Sauer T; Schubert ML; Hückelhoven-Krauss A; Xia R; Ge J; Kleist C; Eckstein V; Sellner L; Müller-Tidow C; Dreger P; Schmitt M; Schmitt A
    Front Immunol; 2021; 12():670088. PubMed ID: 34122428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of cyclooxygenase-2 expression by 4-trifluoromethyl derivatives of salicylate, triflusal, and its deacetylated metabolite, 2-hydroxy-4-trifluoromethylbenzoic acid.
    Fernández de Arriba A; Cavalcanti F; Miralles A; Bayón Y; Alonso A; Merlos M; García-Rafanell J; Forn J
    Mol Pharmacol; 1999 Apr; 55(4):753-60. PubMed ID: 10101034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New pyridazine derivatives as selective COX-2 inhibitors and potential anti-inflammatory agents; design, synthesis and biological evaluation.
    Ahmed EM; Hassan MSA; El-Malah AA; Kassab AE
    Bioorg Chem; 2020 Jan; 95():103497. PubMed ID: 31838289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design, synthesis, and pharmacological evaluation of novel and selective COX-2 inhibitors based on celecoxib scaffold supported with in vivo anti-inflammatory activity, ulcerogenic liability, ADME profiling and docking study.
    Abdellatif KRA; Abdelall EKA; Elshemy HAH; Philoppes JN; Hassanein EHM; Kahk NM
    Bioorg Chem; 2022 Mar; 120():105627. PubMed ID: 35065465
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Non-steroidal anti-inflammatory agents with selective inhibitory activity on cyclooxygenase-2. Interest and future prospects].
    Blain H; Jouzeau JY; Netter P; Jeandel C
    Rev Med Interne; 2000 Nov; 21(11):978-88. PubMed ID: 11109595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selectivity of nonsteroidal antiinflammatory drugs as inhibitors of constitutive and inducible cyclooxygenase.
    Mitchell JA; Akarasereenont P; Thiemermann C; Flower RJ; Vane JR
    Proc Natl Acad Sci U S A; 1993 Dec; 90(24):11693-7. PubMed ID: 8265610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.